Showing results (181-190 of 341) with videos related to
Sort By:
Pageof 35
Journal of Substance Abuse Treatment|July 1, 1995
Does Alcoholics Anonymous involvement predict treatment outcome?H A Montgomery, W R Miller, J S ToniganEuropean Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1985
An analysis of the content and morphology of human breast microcystsJ M Dixon, W N Scott, W R MillerThe Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Relationship between tumour aromatase activity, tumour characteristics and response to therapyW R Miller, T J Anderson, W J JackBMJ (Clinical Research Ed.)|October 14, 1995
Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast GroupC C McDonald, F E Alexander, B W Whyte, et al.Clinical Oncology|June 1, 1984
Clinical assessment of tumour size in primary breast carcinomaJ M Dixon, R O Senbanjo, T J Anderson, et al.British Medical Journal|December 26, 1970
Benign and malignant breast disease in South Wales: a study of urinary steroidsE H Cameron, K Griffiths, E Gleave, et al.Journal of Chromatography. B, Biomedical Applications|April 12, 1996
Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in plasmaJ MacCallum, J Cummings, J M Dixon, et al.International Journal of Cancer|September 17, 1996
Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell linesP Mullen, A Ritchie, S P Langdon, et al.The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomesJ M Dixon, J Jackson, L Renshaw, et al.British Journal of Cancer|May 19, 2000
Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumoursJ MacCallum, J Cummings, J M Dixon, et al.Pageof 35